| MNPR Shares Outstanding History Table | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Below is a table of the MNPR shares outstanding history going back to 12/19/2019:
Also see: MNPR Market Cap History MNPR YTD Return |
MNPR Shares Outstanding History — Monopar Therapeutics Share Count Over Time
As of 7/31/2026 Monopar Therapeutics has 6.71 million MNPR shares outstanding. Investors often track the MNPR shares outstanding history to compare shareholder return trends against the change in share count over time.
This page shows MNPR share count trends over time, with 27 historical shares outstanding datapoints presented, dating back to 12/19/2019.
| MNPR Shares Outstanding History Chart | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||
MNPR Historical Shares Outstanding: +19.33% CAGR 
Mouse over chart for data details
| |||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| MNPR Stock Price Chart |
| About Monopar Therapeutics Inc |
| Monopar Therapeutics Inc. is a clinical-stage biopharmaceutical company focused on developing treatments for cancer patients. Co. is building a drug candidate pipeline through in-house development as well as the licensing and acquisition of therapeutics in late preclinical and in clinical development stages. Co. has several compounds in development, which include MNPR-101-Zr, MNPR-101-RIT, Camsirubicin and MNPR-202. MNPR-101-Zr is a clinical-stage urokinase plasminogen activator receptor (uPAR)-targeted radio diagnostic imaging agent. MNPR-101-RIT is a late preclinical stage radiotherapeutic for advanced cancers. We show 27 historical shares outstanding datapoints in our coverage of MNPR's shares outstanding history. Understanding the changing numbers of MNPR shares outstanding — and comprehending the concept of differing number of shares outstanding in general comparing companies like MNPR versus peers — is critical for investors. Many "beginner" or "novice" investors will look at one stock trading at a price of $10 per share and another trading at a price of $20 per share and think the latter company is worth twice as much. Of course, that is a completely meaningless comparison without also knowing how many shares outstanding there are for each of the two companies. Furthermore, via issuance of new shares over time, or the repurchase of existing shares, the number of shares outstanding can fluctuate over the course of history. With this page we aim to empower investors researching MNPR by allowing them to research MNPR shares outstanding history as well as any other stock in our coverage universe. |
| MNPR Current Stock Quote |
Quotes delayed 20 minutes  Free MNPR Email Alerts:
Get Dividend Alerts 
Get SEC Filing Alerts
|
| Video: Shares Outstanding Importance | |
|
Video: Shares Outstanding Importance
| MNPR Share Performance |
| Shares Outstanding Peers |
| Monopar Therapeutics (MNPR) is categorized under the Healthcare sector; to help you further research historical shares outstanding numbers, below are some other companies in the same sector:
MNTA Shares Outstanding History MODD Shares Outstanding History MODV Shares Outstanding History MOH Shares Outstanding History MORF Shares Outstanding History MOTS Shares Outstanding History MOVE Shares Outstanding History MRIC Shares Outstanding History MRK Shares Outstanding History MRKR Shares Outstanding History More Healthcare companies » |
MNPR Shares Outstanding History | www.SharesOutstandingHistory.com | Copyright © 2017 - 2026, All Rights Reserved
Nothing in SharesOutstandingHistory.com is intended to be investment advice, nor does it represent the opinion of, counsel
from, or recommendations by BNK Invest Inc. or any of its affiliates, subsidiaries or partners.
None of the information contained herein constitutes a recommendation that any particular security, portfolio,
transaction, or investment strategy is suitable for any specific person. All viewers agree that under no
circumstances will BNK Invest, Inc,. its subsidiaries, partners, officers, employees, affiliates, or agents be held
liable for any loss or damage caused by your reliance on information obtained. By visiting, using or viewing this site, you
agree to the following Full Disclaimer & Terms of Use and
Privacy Policy. Video widget and market videos powered by Market News Video. Quote and option data delayed at
least 15 minutes; stock quote data powered by Ticker Technologies, and Mergent.
